Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients

Kei Moriya, Tadashi Namisaki, Shinya Sato, Masanori Furukawa, Akitoshi Douhara, Hideto Kawaratani, Kosuke Kaji, Naotaka Shimozato, Yasuhiko Sawada, Soichiro Saikawa, Hiroaki Takaya, Koh Kitagawa, Takemi Akahane, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji

Clin Mol Hepatol. 2019;25(4):381-389. Published online August 13, 2019

DOI: https://doi.org/10.3350/cmh.2019.0037

View: 6002 Download: 141 Web of Science: 12 Crossref: 12

3

Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated Liver cirrhosis

Sung Hoa Lee, M.D., Seung Ha Park, M.D., Go Woon Kim, M.D., Woo Jin Lee, M.D., Won Ki Hong, M.D., Myeong Shin Ryu, M.D., Kyu Tae Park, M.D., Min Young Lee, M.D., Chan Woo Lee, M.D., Jin Ho Kim, M.D., Yong Mook Kim, M.D., Sung Jung Kim, M.D., Gwang Ho Baik, M.D., Jin Bong Kim, M.D., Dong Joon Kim, M.D.

Clin Mol Hepatol. 2009;15(3):350-356. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.350

View: 5505 Download: 30 Crossref: 3

Thrombocytopenia between Decompensated Alcoholic and Viral Liver Cirrhosis

Eun Sil Koo, M.D., Byung Ik Kim, M.D., Si Young Kim, M.D., Yong Kyun Cho, M.D. Chang Sub Kim, M.D., Chang Young Park, M.D., Chong Il Sohn, M.D., Woo Kyu Jeon, M.D. Eul Soon Jung, M.D. Dong Kug Kum, M.D.*, Young Rae Lee, M.D.† Hwa Young Lee, M.D.‡ , Sang Jong Lee, M.D.‡

Clin Mol Hepatol. 2000;6(2):215-222. Published online January 1, 2000

View: 2429 Download: 25

1 |

Viewed By 5095	MAFLD: How is it different from NAFLD?
Viewed By 5072	Examining the therapeutic landscape of beta-blockers in portal hypertension
Viewed By 4497	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4471	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4363	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 248	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 198	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 145	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 138	MAFLD: How is it different from NAFLD?
Cited By 113	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search